Published in Patient Care Law Weekly, May 2nd, 2004
The far-reaching collaboration is designed to help medical centers, pharmaceutical companies, and research institutions use advanced technologies to integrate genomic research data with patient clinical data, to help reduce healthcare costs, improve patient care, and provide more targeted treatment solutions.
Under the agreement, IBM and Affymetrix will combine open standards technologies, including the Affymetrix GeneChip technology and IBM professional services, in areas such as regulatory compliance, business...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Patient Care Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.